The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance

Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

(2013) Patrick Haentjens   ANNALS OF INTERNAL MEDICINE

Population pharmacokinetic-pharmacodynamic analysis for eribulin mesilate-associated neutropenia

(2013) J. G. Coen van Hasselt et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation of Tumor-Size Response Metrics to Predict Overall Survival in Western and Chinese Patients With First-Line Metastatic Colorectal Cancer

(2013) Laurent Claret et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of a Framework for Cohort Simulation in Cost-Effectiveness Analyses Using a Multistep Ordinary Differential Equation Solver Algorithm in R

(2013) Gerardus W. J. Frederix et al.   MEDICAL DECISION MAKING

Improving the Accuracy and Comparability of Model-Based Economic Evaluations of Health Technologies for Reimbursement Decisions

(2012) Hossein Haji Ali Afzali et al.   MEDICAL DECISION MAKING

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

(2012) Andrew H. Briggs et al.   VALUE IN HEALTH

Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer

(2011) Stefan Glück et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

(2011) Mohammad H Forouzanfar et al.   LANCET

A Framework for Addressing Structural Uncertainty in Decision Models

(2011) Christopher H. Jackson et al.   MEDICAL DECISION MAKING

Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies: Influence of Differences in Modeling Methods on Outcomes

(2011) Gerardus W.J. Frederix et al.   VALUE IN HEALTH

Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review

(2010) Sekwon Jang et al.   BREAST CANCER RESEARCH AND TREATMENT

Modeling in pharmacoeconomic studies: Funding sources and outcomes

(2010) Livio Garattini et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System

(2010) Michael P. Lux et al.   ONKOLOGIE

Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil

(2009) Marcelo Fonseca et al.   Revista da Associacao Medica Brasileira

Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods

(2009) Laura Bojke et al.   VALUE IN HEALTH

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer

(2008) S. L. Hines et al.   ANNALS OF ONCOLOGY

Internal Mammary Nodes in Breast Cancer: Diagnosis and Implications for Patient Management—A Systematic Review

(2008) Ronald C. Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer

(2008) Lieven Annemans   PHARMACOECONOMICS